Royce & Associates’s Athenahealth, Inc. ATHN Stock Holding History

Royce & Associates’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-32,500	Closed	-$4.29M	–	1225
2018 Q4	$4.29M	Hold	32,500	–	–	0.04%	543
2018 Q3	$4.34M	Hold	32,500	–	–	0.03%	633
2018 Q2	$5.17M	Sell	32,500 -100,725	-76%	-$14.9M	0.04%	580
2018 Q1	$19.1M	Sell	133,225 -10,280	-7%	-$1.4M	0.13%	206
2017 Q4	$19.1M	Sell	143,505 -14,895	-9%	-$1.9M	0.13%	226
2017 Q3	$19.7M	Hold	158,400	–	–	0.13%	227
2017 Q2	$22.3M	Buy	158,400 +50,000	+46%	+$6.25M	0.15%	197
2017 Q1	$12.2M	Buy	+108,400	New	+$12.6M	0.08%	329

Royce & Associates's ATHN Position: Q1 2019 in Review

Royce & Associates sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 32,500 shares — an estimated $4.29M sold.

Royce & Associates first reported a position in ATHN in Q1 2017 and held it in 8 quarters. The position peaked at $22.3M in Q2 2017. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

Royce & Associates reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
Royce & Associates sold 32,500 Athenahealth, Inc. shares in Q1 2019, an estimated $4.29M.
Royce & Associates first reported a position in Athenahealth, Inc. in Q1 2017 and held it in 8 quarters.
Royce & Associates's Athenahealth, Inc. position peaked at $22.3M in Q2 2017.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Royce & Associates's 13F filing for Q1 2019, filed 9 May 2019.